Ultrasound platform effective evaluating hepatic steatosis

Thursday, November 30 | 1:30 p.m.-1:40 p.m. | R6-SSGI19-1 | Room E352Attendees will hear about the potential for ultrasound-derived fat fraction to be an alternative tool for MRI in assessing hepatic steatosis.Yi Dong, MD, from Fudan University in Shanghai, China, will present findings that show how ultrasound-derived fat fraction can detect hepatic steatosis using MRI-derived proton density fat fraction as the reference standard.Several ultrasound platforms now provide quantitative measures of hepatic steatosis. One of these is ultrasound-derived fat fraction, which combines attenuation and backscatter quantification. In their study, Dong and colleagues wanted to explore the role of this platform in detecting and assessing hepatic steatosis, with MRI-derived proton density fat fraction being used as the reference standard.They included 113 participants in their prospective study. Of these, 39 had type 2 diabetes mellitus while 76 had nonalcoholic fatty liver disease. The team reported that the median ultrasound-derived fat fraction in the patients was 9.2%.It also found good correlation between ultrasound-derived fat fraction and MRI-derived proton density fat fraction (p = 0.764, p 
Source: AuntMinnie.com Headlines - Category: Radiology Authors: Tags: 2023 Ultrasound Preview Source Type: news